Statistics for Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels
Total visits
| views | |
|---|---|
| Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels | 84 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| 12917_2016_Article_775.pdf | 43 |
| 12917_2016_Article_775.pdf(legacy) | 25 |
Top country views
| views | |
|---|---|
| United States | 59 |
| Germany | 17 |
| France | 10 |
| Malaysia | 10 |
| United Kingdom | 9 |
| Jamaica | 6 |
| China | 3 |
| Sweden | 2 |
| Canada | 1 |
| Côte d’Ivoire | 1 |
| Italy | 1 |
| Saudi Arabia | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Kuala Lumpur | 10 |
| Southend | 9 |
| Kingston | 6 |
| Mountain View | 4 |
| Abidjan | 1 |
| Beijing | 1 |
| Des Moines | 1 |
| Hanoi | 1 |
| Heidelberg | 1 |
| Schwann | 1 |